Home

sziréna Megkülönböztetés mikroszkopikus he4 ca125 tumor marker Fordul Rossz sors zálog

Performance of preoperative plasma tumor markers HE4 and CA125 in  predicting ovarian cancer mortality in women with epithelial ovarian cancer  | PLOS ONE
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE

CA125 and HE4 levels pre and post treatment for endometrial cancer |  Download Table
CA125 and HE4 levels pre and post treatment for endometrial cancer | Download Table

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer -  ScienceDirect
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer - ScienceDirect

Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination  with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care  Population
Cancers | Free Full-Text | The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population

PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian  cancer | Semantic Scholar
PDF] The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar

Clinical analysis of four serum tumor markers in 458 patients with ova |  CMAR
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity  and prognosis in epithelial ovarian cancer | Journal of Ovarian Research |  Full Text
Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer | Journal of Ovarian Research | Full Text

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor  Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero,  - ppt video online download
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download

Performance of preoperative plasma tumor markers HE4 and CA125 in  predicting ovarian cancer mortality in women with epithelial ovarian cancer  | PLOS ONE
Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer | PLOS ONE

JCM | Free Full-Text | Efficacy of HE4, CA125, Risk of Malignancy Index and  Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with  Presumed Benign Ovarian Tumours: A Prospective,
JCM | Free Full-Text | Efficacy of HE4, CA125, Risk of Malignancy Index and Risk of Ovarian Malignancy Index to Detect Ovarian Cancer in Women with Presumed Benign Ovarian Tumours: A Prospective,

Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review
Cancers | Free Full-Text | CA125 and Ovarian Cancer: A Comprehensive Review

Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting  with a suspicious cystic ovarian mass
Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass

The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian  cancer
The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer

Tumor marker (composed of CA125 and HE4) after surgery, during... |  Download Scientific Diagram
Tumor marker (composed of CA125 and HE4) after surgery, during... | Download Scientific Diagram

A multiplex biomarker assay improves the diagnostic performance of HE4 and  CA125 in ovarian tumor patients | PLOS ONE
A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients | PLOS ONE

Reference ranges for HE4 and CA125 in a large Asian population by automated  assays and diagnostic performances for ovarian cancer - Park - 2012 -  International Journal of Cancer - Wiley Online Library
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library

Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human  Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer

SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy  algorithm (ROMA), and risk malignancy index (RMI) for the classification of  ovarian masses A comparison of CA125, HE4, risk ovarian
SciELO - Brasil - A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses A comparison of CA125, HE4, risk ovarian

PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a  clinical setting. | Semantic Scholar
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar

Clinical analysis of four serum tumor markers in 458 patients with ova |  CMAR
Clinical analysis of four serum tumor markers in 458 patients with ova | CMAR

Ovarian Cancer | AACC.org
Ovarian Cancer | AACC.org

Reference ranges for HE4 and CA125 in a large Asian population by automated  assays and diagnostic performances for ovarian cancer - Park - 2012 -  International Journal of Cancer - Wiley Online Library
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library

HE4 and CA125 as a diagnostic test in ovarian cancer: prospective  validation of the Risk of Ovarian Malignancy Algorithm | British Journal of  Cancer
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer

Past, Present, and Future of Serum Tumor Markers in Management of Ovarian  Cancer: A Guide for the Radiologist | RadioGraphics
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics

PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a  clinical setting. | Semantic Scholar
PDF] No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting. | Semantic Scholar

Reference ranges of HE4 and CA125 according to age group | Download Table
Reference ranges of HE4 and CA125 according to age group | Download Table

OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos
OncoOVARIAN Dx – Ovarian Cancer Diagnosis Test – Bioprognos